Trial Details
COMPLETEDBasic Information
| Clinical ID | c3052 |
|---|---|
| Identifier | NCT02590432 |
| Trial Title | An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation|Chronic Idiopathic Constipation |
| Interventions | DRUG: Linaclotide |
Participant Information
| Sponsor | Forest Laboratories |
|---|---|
| City | Anniston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2015-11-01 |
|---|---|
| Primary Completion Date | 2018-02-05 |
| Completion Date | 2018-02-05 |